Enzyme (MLN) community buzzes about surpassing $200M in AUM and new partnerships with Polygon & Yearn. Despite this growth, discussions highlight ongoing selling pressure. All eyes are on the upcoming Mainnet 2.0 launch to potentially drive momentum.